Trexquant Investment LP - PDS BIOTECHNOLOGY CORP ownership

PDS BIOTECHNOLOGY CORP's ticker is PDSB and the CUSIP is 70465T107. A total of 54 filers reported holding PDS BIOTECHNOLOGY CORP in Q1 2022. The put-call ratio across all filers is 0.26 and the average weighting 0.0%.

Quarter-by-quarter ownership
Trexquant Investment LP ownership history of PDS BIOTECHNOLOGY CORP
ValueSharesWeighting
Q3 2023$130,548
-44.3%
25,851
-32.2%
0.00%
-50.0%
Q1 2023$234,377
-26.3%
38,110
+58.1%
0.01%
-33.3%
Q4 2022$318,226
+478.6%
24,108
+59.1%
0.01%
+350.0%
Q2 2022$55,000
-89.5%
15,151
-82.1%
0.00%
-92.0%
Q1 2022$524,000
+49.3%
84,587
+95.1%
0.02%
+13.6%
Q4 2021$351,000
-44.5%
43,366
+2.3%
0.02%
-56.0%
Q3 2021$632,00042,3860.05%
Other shareholders
PDS BIOTECHNOLOGY CORP shareholders Q1 2022
NameSharesValueWeighting ↓
AIGH Capital Management LLC 1,499,149$18,814,0003.39%
New Leaf Venture Partners, L.L.C. 117,242$7,975,0002.05%
Worth Venture Partners, LLC 348,703$4,376,0001.63%
INSPIRION WEALTH ADVISORS, LLC 253,262$3,178,0000.78%
EAM Global Investors LLC 187,900$2,358,0000.65%
EAM Investors, LLC 279,613$3,509,0000.54%
ACT CAPITAL MANAGEMENT, LLC 45,000$565,0000.29%
Andesa Financial Management Inc. 33,310$418,0000.13%
Monashee Investment Management LLC 80,000$1,004,0000.12%
Sofinnova Investments, Inc. 142,635$1,790,0000.10%
View complete list of PDS BIOTECHNOLOGY CORP shareholders